IGF2BP1 and cancer: Recently, it was widely reported that IGF2BP1 as a m6A “reader” involved in tumor immune microenvironment (TME) regulation activated immune cell infiltration and promoted cancer development by recognizing m6A target transcripts (Elcheva et al. 2023; Liu et al. 2022a, b).